Onkolojide Nörolojik Sorunlar ve Acil Yaklaşım
Özet
Kanserin nörolojik komplikasyonları yaygındır ve sıklıkla hayatı tehdit eden olaylardır. Kanser hastalarında belirli nörolojik acil durumlar daha sık görülmektedir; bunlar arasında artmış intrakraniyal basınç, epidural omurilik basısı, status epileptikus, iskemik ve hemorajik inme, merkezi sinir sistemi enfeksiyonu ve tedaviye bağlı nörolojik disfonksiyon bulunmaktadır. Bu acil durumlar, en iyi sonucu sağlamak için erken tanı ve hızlı tedavi gerektirir. Bu bölümde, kanserli hastalarda akut nörolojik dekompansasyonun en yaygın nedenlerinin sunumu, patofizyolojisi ve yönetimini gözden geçirmeyi amaçladık.
Referanslar
Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol. 2004; 11:89–104. [PubMed: 15259863]
Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001; 56:1746–1748. [PubMed: 11425944]
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993; 43:1678–1683. [PubMed: 8414011]
Agrawal A, Timothy J, Cincu R, Agarwal T, Waghmare LB. Bradycardia in neurosurgery. Clin Neurol Neurosurg. 2008; 110:321–327. [PubMed: 18329164]
Koenig MA, Bryan M, Lewin JL 3rd, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008; 70:1023–1029. [PubMed: 18272864]
Giacino JT, Smart CM. Recent advances in behavioral assessment of individuals with disorders of consciousness. Curr Opin Neurol. 2007; 20:614–619. [PubMed: 17992078]
Woessner H, Vibhute P, Barrett K. Acute loss of bladder control in a stroke of the frontal cortex. Neurohospitalist. 2012; 2:129–131. [PubMed: 23983877]
Ryken TC, McDermott M, Robinson PD, et al. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2010; 96:103–114. [PubMed: 19957014]
de la Fuente MI, DeAngelis LM. The role of ventriculoperitoneal shunting in patients with supratentorial glioma. Ann Clin Transl Neurol. 2014; 1:45–48. [PubMed: 25356380]
Andrew L. Lin, M.D. and Edward K. Avila, D.O., Neurologic Emergencies in the Cancer Patient: Diagnosis and Management, J Intensive Care Med. 2017 February ; 32(2): 99–115. doi:10.1177/0885066615619582.
11.Cadena R: Understanding ACEP’s clinical policy on seizures. Emergency Physicians Monthly, September 20-21, 2014.
Theodore PR: Emergent management of malignancy-related acute airway obstruction. Emerg Med Clin North Am 27: 231, 2009. [PMID: 19447308]
Coleman RE: Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12: 6243s, 2006. [PMID: 17062708]
Kane CM, Hoskin P, Bennett MI: Cancer induced bone pain. BMJ 350: h315, 2015. [PMID: 25633978]
Soeharno H, Povegliano L, Choong PF: Multimodal treatment of bone metastasis: a surgical perspective. Front Endocrinol (Lausanne) 9: 518, 2018. [PMID: 30245668]
Hammack JE. Spinal cord disease in patients with cancer. Continuum (Minneap Minn). 2012; 18:312–327. [PubMed: 22810129]
Gemici C. Lhermitte's sign: Review with special emphasis in oncology practice. Crit Rev Oncol Hematol. 2010; 74:79–86. [PubMed: 19493683]
Laird AS, Finch AM, Waite PM, Carrive P. Peripheral changes above and below injury level lead to prolonged vascular responses following high spinal cord injury. Am J Physiol Heart Circ Physiol. 2008; 294:H785–792. [PubMed: 18055525]
Nater A, Sahgal A, Fehlings M: Management: spinal metastases. Handb Clin Neurol 149: 239, 2018. [PMID: 29307356]
Lestuzzi C, Berretta M, Tomkowski W: 2015 update on the diagnosis and management of neoplastic pericardial disease. Expert Rev Cardiovasc Ther 13: 377, 2015. [PMID: 25797903]
Virk SA, Chandrakumar D, Villanueva C, Wolfenden H, Liou K, Cao C: Systematic review of percutaneous interventions for malignant pericardial effusion. Heart 101: 1619, 2015. [PMID: 26180077]
Zimmerman S, Davis M: Rapid fire: superior vena cava syndrome. Emerg Med Clin North Am 36: 577, 2018. [PMID: 30037444]
Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes [published correction appears in N Engl J Med. 2008;358(10):1083]. N Engl J Med. 2007;356(18): 1862-1869.
Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: pathophysiology, presentation, diagnosis, and treatment [published correction appears in CA Cancer J Clin. 2011;61(6):420]. CA Cancer J Clin. 2011;61(5):287-314.
Kahale LA, Tsolakian IG, Hakoum MB, et al: Anticoagulation for people with cancer and central venous catheters. Cochrane Database Syst Rev 6: CD006468, 2018. [PMID: 29856471]
McCurdy MT, Shanholtz CB. Oncologic emergencies. Crit Care Med. 2012;40(7):2212-2222.
Lumachi F, Brunello A, Roma A, Basso U: Cancer-induced hypercalcemia. Anticancer Res 29: 1551, 2009. [PMID: 19443365]
Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR: Adrenal crisis: still a deadly event in the 21st century. Am J Med 129: 339.e1, 2016. [PMID: 26363354]
Dubbs SB: Rapid fire: tumor lysis syndrome. Emerg Med Clin North Am 36: 517, 2018. [PMID: 30037438]
Cantwell L, Perkins J: Infectious disease emergencies in oncology patients. Emerg Med Clin North Am 36: 795, 2018. [PMID: 30297005]
Taplitz RA, Kennedy EB, Bow EJ, et al: Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice guideline update. J Clin Oncol 36: 1443, 2018. [PMID: 29461916]
Heinz WJ, Buchheidt D, Christopeit M, et al: Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96: 1775, 2017. [PMID: 28856437]
Ng C, Slavin MA, Seymour JF. Progressive multifocal leukoencephalopathy complicating Waldenstrom's macroglobulinaemia. Leuk Lymphoma. 2003; 44:1819–1821. [PubMed: 14692541]
Stone MJ, Bogen SA: Evidence-based focused review of management of hyperviscosity syndrome. Blood 119: 2205, 2012. [PMID: 22147890]
Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2011; 42:1158–1192. [PubMed: 21293023]
Lee AYY: Overview of VTE treatment in cancer according to clinical guidelines. Thromb Res 164: S162, 2018. [PMID: 29307469]
Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007; 68:932–938. [PubMed: 17372129]
Bernstein, M., Berger, MS. Neuro-oncology : the essentials. Third.
Heuts SG, Bruce SS, Zacharia BE, et al. Decompressive hemicraniectomy without clot evacuation in dominant-sided intracerebral hemorrhage with ICP crisis. Neurosurg Focus. 2013; 34:E4.
Lee EQ, Arrillaga-Romany IC, Wen PY. Neurologic complications of cancer drug therapies. Continuum (Minneap Minn). 2012; 18:355–365. [PubMed: 22810132]
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995; 333:1581–1587. [PubMed: 7477192]
Pfefferkorn T, Mayer TE, Opherk C, et al. Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients. Stroke. 2008; 39:1496–1500. [PubMed: 18323481]
Janelsins MC, Tejani MA, Kamen C, Peoples AR, Mustian KM, Morrow GR: Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother 14: 757, 2013. [PMID: 23496347]
Kimmel J, Fleming P, Cuellar S, Anderson J, Haaf CM: Pharmacological management of anticancer agent extravasation: a single institutional guideline. J Oncol Pharm Pract 24: 129, 2018. [PMID: 29284352]
Kroschinsky F, Stolzel F, von Bonin S, et al: New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management. Crit Care 21: 89, 2017. [PMID: 28407743]
Lee EQ, Arrillaga-Romany IC, Wen PY. Neurologic complications of cancer drug therapies. Continuum (Minneap Minn). 2012; 18:355–365. [PubMed: 22810132]
Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prove A, Vermorken JB. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer. 2000; 82:291–294. [PubMed: 10646879]
Szawarski P, Chapman CS. A woman who couldn't speak: report of methotrexate neurotoxicity. Postgrad Med J. 2005; 81:194–195. [PubMed: 15749798]
DeAngelis, LM., Posner, JB., Posner, JB. Neurologic complications of cancer. 2nd. Oxford; New York: Oxford University Press; 2009.
Liao B, Shroff S, Kamiya-Matsuoka C, Tummala S. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol. 2014; 16:589–593. [PubMed: 24482447]
Davila ML, Riviere I, Wang X, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014; 6:224ra225.